For the quarter ended March 2026, MannKind (MNKD Quick QuoteMNKD - Free Report) reported revenue of $90.17 million, up 15.1% over the same period last year. EPS came in at -$0.05, compared to $0.04 in the year-ago quarter.

The reported revenue represents a surprise of -13.05% over the Zacks Consensus Estimate of $103.7 million. With the consensus EPS estimate being -$0.02, the EPS surprise was -150%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how MannKind performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Royalties: $32.75 million versus $33.9 million estimated by two analysts on average.
• Revenues- Commercial product sales: $33.91 million versus $41.65 million estimated by two analysts on average.
• Revenue- Furoscix: $15.49 million versus $18.72 million estimated by two analysts on average.
• Revenue- Afrezza: $15.27 million versus the two-analyst average estimate of $19.13 million.
• Revenue- V-Go: $3.14 million compared to the $3.8 million average estimate based on two analysts.
• Revenues- Collaborations and services: $23.52 million compared to the $27.21 million average estimate based on two analysts.

View all Key Company Metrics for MannKind here>>>

Shares of MannKind have returned +11.3% over the past month versus the Zacks S&P 500 composite's +10.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.